Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22253485 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
Condition: Macular Degeneration
Intervention: Drug: Ranibizumab

Study has passed its completion date and status has not been verified in more than two years.